Aptus Pharma to raise Rs 45 crore via preferential issue
Aptus Pharma plans to raise Rs 45 crore through a preferential issue of shares, subject to shareholder approval at its Annual General Meeting on September 14, 2026. The proceeds will be used…
All posts tagged in pharmaceuticals
15Articles
NITI Aayog identifies sectors to make India a manufacturing hub
NITI Aayog has released a report outlining key sectors to position India as a global manufacturing hub. The report focuses on high-growth industries such as electronics, automotive components, pharmaceuticals, and textiles, aiming…
India’s chemical pump market to grow steadily till 2035
India's chemical pump market is set for steady expansion through 2035, driven by industrial capital expenditure, stricter environmental regulations, and replacement demand, according to IndexBox. The market, estimated at Rs 8,000 crore…
India’s export growth relies on Chinese imports, data shows
India's merchandise exports grew 17.04% in April-July 2026 compared to the same period last year, but imports surged 19.27% to $292.38 billion, driven largely by Chinese components for smartphones and pharmaceuticals, ThePrint…
Gland Pharma Q1 net jumps 47% to Rs 317 crore on revenue
Gland Pharma reported a 47% year-on-year jump in consolidated net profit to Rs 317 crore for the June quarter, driven by a 20% rise in revenue to Rs 1,800.3 crore. Sequentially, net…
Wockhardt gets USFDA nod for novel drug Zaynich
Wockhardt has received US Food and Drug Administration approval for Zaynich, a novel drug discovered and developed in-house, marking a first for an Indian pharmaceutical company. The company spent nearly Rs 6,800…
China’s drug race slows as lab monkey prices surge
China’s fast-growing pharmaceutical industry is facing a shortage of lab monkeys, pushing the price of a cynomolgus macaque to 178,000 yuan, about Rs 22 lakh, in June 2026. The price has more…
Novartis India appoints Rahul Vijayvargiya as CHRO
Novartis India has appointed Rahul Vijayvargiya as its Chief Human Resources Officer. Vijayvargiya announced the appointment in a LinkedIn post, saying he had started the new role at Novartis India Limited.
Biocon calls US generic drug tariffs a negotiation tactic
Biocon will wait before changing its US strategy, while exploring partnerships for local manufacturing if required, executive chairperson Kiran Mazumdar-Shaw told Mint. She said proposed tariffs were more likely a negotiating threat…
Biocon Q1 Income Rises 9% as Biopharma Revenue Grows 17%
Biocon’s total income rose 9 per cent year on year to Rs 4,391 crore in the first quarter of FY27, Business Today TV reported. EBITDA stood at Rs 902 crore and net…
- 1
- 2
